Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN amyloid-β protein
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
University of Missouri–St. Louis names George Nnanna founding director of new School of Engineering
Nnanna was the founding dean of the College of Engineering at the University of Texas Permian Basin from 2018 to 2023 and more recently has been the director of its Texas Water and Energy Institute.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
MORE IN amyloid-β protein
LATEST NEWS
- University of Missouri–St. Louis names George Nnanna founding director of new School of Engineering
- BSN graduate Madison Zerban working as a pediatric hematology and oncology nurse at St. Louis Children’s Hospital
- Eye on UMSL: Foundation for the future
- UMSL Tritons weekly rewind
- UMSL alum Nicole Northway designs bamboo pajamas with personality at Emerson and Friends
- Year in review: UMSL sees transformative change during 2024
- Social work student marshal Zeth Crews grows professionally at Places for People
- Veteran Ryan Manley graduates with information systems and technology degree
- Sociology graduate Addi Nunnelly applying lessons from the classroom in her work in the community
- New Doctor of Business Administration cohort features students with diverse professional backgrounds
